Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)Ugo Giovanni Falagario, Giuseppe Carrieri, Erik Skaaheim Haug et al.|European Urology Oncology|2020Cited by 105
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate CancerAlberto Martini, Alberto Briganti, Giorgio Gandaglia et al.|European Urology Oncology|2019Cited by 86
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02Andrea Necchi, Francesco Montorsi, Alberto Martini et al.|Urologic Oncology Seminars and Original Investigations|2021Cited by 42
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk ScoreMax Peters, Hashim U. Ahmed, David Eldred‐Evans et al.|European Urology|2022Cited by 38
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Alberto Briganti, Giorgio Gandaglia et al.|European Urology Oncology|2018Cited by 21